BGM GROUP LTD (BGM) Stock Price, Forecast & Analysis

NASDAQ:BGM • KYG7307E1237

0.965 USD
-0.08 (-7.21%)
At close: Feb 23, 2026
0.9649 USD
0 (-0.01%)
After Hours: 2/23/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

BGM Key Statistics, Chart & Performance

Key Statistics
Market Cap156.77M
Revenue(TTM)26.85M
Net Income(TTM)-2.72M
Shares162.46M
Float51.75M
52 Week High17.17
52 Week Low0.96
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.28
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-01-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
BGM short term performance overview.The bars show the price performance of BGM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

BGM long term performance overview.The bars show the price performance of BGM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BGM is 0.965 USD. In the past month the price decreased by -74.06%. In the past year, price decreased by -89.82%.

BGM GROUP LTD / BGM Daily stock chart

BGM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
BGM Full Technical Analysis Report

BGM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BGM. While BGM seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BGM Full Fundamental Analysis Report

BGM Financial Highlights

Over the last trailing twelve months BGM reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 74.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.31%
ROE -1.49%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-146.9%
Sales Q2Q%13.92%
EPS 1Y (TTM)74.4%
Revenue 1Y (TTM)-10.12%
BGM financials

BGM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
BGM Analyst EstimatesBGM Analyst Ratings

BGM Ownership

Ownership
Inst Owners0.2%
Ins Owners25.02%
Short Float %0.13%
Short Ratio1.37
BGM Ownership

BGM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO31.54954.38B
JNJ JOHNSON & JOHNSON21.1584.231B
MRK MERCK & CO. INC.22.88303.452B
PFE PFIZER INC9.01151.524B
BMY BRISTOL-MYERS SQUIBB CO10.07123.489B
ZTS ZOETIS INC18.3256.752B
RPRX ROYALTY PHARMA PLC- CL A8.7726.045B
VTRS VIATRIS INC6.3118.336B
ELAN ELANCO ANIMAL HEALTH INC23.6712.412B
AXSM AXSOME THERAPEUTICS INC213.399.261B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About BGM

Company Profile

BGM logo image BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Company Info

BGM GROUP LTD

No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District

Chengdu SICHUAN CN

Employees: 323

BGM Company Website

BGM Investor Relations

Phone: 862864775180

BGM GROUP LTD / BGM FAQ

Can you describe the business of BGM GROUP LTD?

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.


Can you provide the latest stock price for BGM GROUP LTD?

The current stock price of BGM is 0.965 USD. The price decreased by -7.21% in the last trading session.


What is the dividend status of BGM GROUP LTD?

BGM does not pay a dividend.


How is the ChartMill rating for BGM GROUP LTD?

BGM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is BGM GROUP LTD (BGM) stock traded?

BGM stock is listed on the Nasdaq exchange.


What is the market capitalization of BGM stock?

BGM GROUP LTD (BGM) has a market capitalization of 156.77M USD. This makes BGM a Micro Cap stock.


Can you provide the ownership details for BGM stock?

You can find the ownership structure of BGM GROUP LTD (BGM) on the Ownership tab.